Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease

NCT03318276 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DRUG: SID142
DRUG: Rinexin® Tab

Sponsor

SK Chemicals Co., Ltd.